BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20460315)

  • 1. Loose mesothelial cysts in the peritoneal cavity.
    Ramirez Y; Rosai J; Segura JJ
    Int J Surg Pathol; 2010 Jun; 18(3):214-6. PubMed ID: 20460315
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesothelial inclusion cysts (so-called benign cystic mesothelioma)--a clinicopathological analysis of six cases.
    Urbańczyk K; Skotniczny K; Kuciński J; Friediger J
    Pol J Pathol; 2005; 56(2):81-7. PubMed ID: 16092670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicystic peritoneal mesothelioma: report of three cases.
    Charfi S; Chetaille B; Marcy M; Turrini O; Chaise De Maison C; Delpero JR; Viret F; Xerri L; Monges G
    Pathologica; 2008 Oct; 100(5):416-9. PubMed ID: 19253604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations.
    Pisharodi LR; Bedrossian CW
    Diagn Cytopathol; 1996 Nov; 15(4):292-5. PubMed ID: 8982583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
    Comin CE; Saieva C; Messerini L
    Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign multicystic peritoneal mesothelioma: a diagnostic challenge.
    Ng JW; Lau RL; Ng WF
    ANZ J Surg; 2006 May; 76(5):421-2. PubMed ID: 16768710
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
    Ordóñez NG
    Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polycystic mesothelioma of the peritoneum. Description of 4 cases].
    Scattone A; Pennella A; Giardina C; Marinaccio M; Ricco R; Pollice L; Serio G
    Pathologica; 2001 Oct; 93(5):549-55. PubMed ID: 11725357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected topics in peritoneal pathology.
    Baker PM; Clement PB; Young RH
    Int J Gynecol Pathol; 2014 Jul; 33(4):393-401. PubMed ID: 24901399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytology of benign multicystic peritoneal mesothelioma in peritoneal washings.
    Assaly M; Bongiovanni M; Kumar N; Egger JF; Pelte MF; Genevay M; Finci V; Tschanz E; Pache JC
    Cytopathology; 2008 Aug; 19(4):224-8. PubMed ID: 18476992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME (preferentially expressed antigen of melanoma) is a novel marker for differentiating serous carcinoma from malignant mesothelioma.
    Brenne K; Nymoen DA; Reich R; Davidson B
    Am J Clin Pathol; 2012 Feb; 137(2):240-7. PubMed ID: 22261449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilocular peritoneal inclusion cyst--a case report.
    Nayak S; Parate RC; Bobhate S
    Indian J Pathol Microbiol; 2005 Apr; 48(2):247-9. PubMed ID: 16758684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
    Sangoi AR; Soslow RA; Teng NN; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benign peritoneal cystic mesothelioma as differential diagnose of an ovarian dependant tumor. Case report and review of the literature].
    Dueñas García OF; Kerckoff Villanueva H; Rico Olvera H; Lira Plascencia J
    Ginecol Obstet Mex; 2007 Feb; 75(2):111-4. PubMed ID: 17542260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of the peritoneum: a review of selected topics.
    Daya D; McCaughey WT
    Semin Diagn Pathol; 1991 Nov; 8(4):277-89. PubMed ID: 1759060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary malignant deciduoid peritoneal mesothelioma: a report of the cytohistological and immunohistochemical appearances.
    Ustun H; Astarci HM; Sungu N; Ozdemir A; Ekinci C
    Diagn Cytopathol; 2011 Jun; 39(6):402-8. PubMed ID: 21574260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings.
    Fadare O; Mariappan MR; Wang S; Hileeto D; McAlpine J; Rimm DL
    Cancer; 2004 Jun; 102(3):150-6. PubMed ID: 15211473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC2 is a molecular marker for pseudomyxoma peritonei.
    O'Connell JT; Hacker CM; Barsky SH
    Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mesothelial cyst and cystic mesothelioma of the greater omentum:case report and literature review].
    Ignjatović M; Cerović S; Cuk V
    Acta Chir Iugosl; 2001; 48(1):77-83. PubMed ID: 11432259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.